Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2007
10/09/2007US7279279 Contacting a cell with a viral particle in the presence of compound, detecting the expression of indicator gene, comparing the expression detected and a control expression of indicator gene, thereby determining the susceptibility of HIV to compound
10/09/2007US7279277 Identifying fetal cell nuclei, chromosomes or DNA in a maternal blood or vaginal sample; detecting chromosomal aberrations
10/09/2007US7279276 Screening method
10/09/2007US7279274 Method for diagnosing diabetes in a mammal
10/09/2007US7279170 Recombinant polypeptides, which can be used as purified antigens for the detection and control of tuberculosis
10/09/2007US7279158 Methods for the treatment of inflammatory joint disease
10/09/2007US7279136 Diagnostic test kit for detecting the presence of an analyte within a test sample
10/09/2007US7279130 Sensor dispensing instrument having an activation mechanism and methods of using the same
10/09/2007US7279080 Gas sensors
10/09/2007US7278414 Diagnostic tool for sensing oxygen sensor heater operation
10/09/2007US7278330 Method of inspecting porous structure
10/09/2007CA2398795C Image metrics in the statistical analysis of dna microarray data
10/09/2007CA2365654C Apparatus and method for detecting twist in articles
10/09/2007CA2309916C Ultrasonic system for grading meat
10/09/2007CA2309528C Simultaneous determination of forward and reverse abo blood group
10/09/2007CA2272881C Assay method for peptide specific t-cells
10/09/2007CA2190732C Method and apparatus for the collection, storage, and real time analysisof blood and other bodily fluids
10/09/2007CA2184245C Isolation of cellular material under microscopic visualization
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
10/09/2007CA1341554C Neuronal nicotinic acetylcholine receptor compositions and assay
10/04/2007WO2007112444A2 Polymeric sulfated surfactants for capillary electrophoresis (ce) and ce-mass spectrometry (ce-ms)
10/04/2007WO2007112355A2 Hemoglobin-based methods for prophylaxis, diagnosis and/or treatment of retinal disorders
10/04/2007WO2007112350A2 Method of assessing the metastatic status of a primary tumor
10/04/2007WO2007112273A2 Oxidative protection of lipid layer biosensors
10/04/2007WO2007112217A2 Self calibrating measurement system
10/04/2007WO2007112215A2 Optical design of a measurement system having multiple sensor or multiple light source paths
10/04/2007WO2007112214A2 Dual function measurement system
10/04/2007WO2007112212A2 Measurement of light from a predefined scatter angle from particulate matter in a media
10/04/2007WO2007112210A2 Optical design of a particulate measurement system
10/04/2007WO2007112082A2 Methods and compositions for the identification of cancer markers
10/04/2007WO2007112055A2 Apolipoprotein fingerprinting technique
10/04/2007WO2007112054A2 Facilitation of translocation of molecules through the gastrointestinal tract
10/04/2007WO2007112051A2 Polypyrimidine-tract binding protein (ptb) as a biomarker and target for the diagnosis and treatment of cancer
10/04/2007WO2007112012A2 Protein isoform discrimination and quantitative measurements thereof
10/04/2007WO2007112007A2 Immobilized proteins and methods and uses thereof
10/04/2007WO2007111961A2 Method for estimating protein-protein binding affinities
10/04/2007WO2007111938A2 Inflammation-inhibitory serum factors and uses thereof
10/04/2007WO2007111875A2 Methods for diagnosing and treating kidney and colorectal cancer
10/04/2007WO2007111851A1 Use of additives to lower the rate of a binding reaction
10/04/2007WO2007111847A2 Use of additives for the reduction of non-specific binding in assays
10/04/2007WO2007111628A2 Mxa as an antiviral drug and as a target for identification of antiviral drugs for dna virus infections
10/04/2007WO2007111601A1 Detection of hypertension using glucuronidated metabolic products
10/04/2007WO2007111555A1 Device and method for detection of fluorescence labelled biological components
10/04/2007WO2007111179A1 Diagnostic imaging agent for incurable neuron disease
10/04/2007WO2007111001A1 Device for measuring urine flow rate
10/04/2007WO2007110756A2 Assay device and method with magnetic field and time-varying signals
10/04/2007WO2007110739A2 Method and apparatus for the processing and/or analysis and/or selection of particles, in particular biological particles
10/04/2007WO2007110644A2 Hereditary cataract status im canines based on hsf4 gene marker
10/04/2007WO2007110623A2 Screening method
10/04/2007WO2007110605A2 Fluorescence based detection of substances
10/04/2007WO2007110359A1 Means and methods for the differentiation of acute and chronic myocaridal necrosis in symptomatic patients
10/04/2007WO2007110358A2 Means and method for predicting diabetes
10/04/2007WO2007110357A2 Means and method for diagnosing diabetes
10/04/2007WO2007110249A1 Use of the 4-1bb receptor for identifying and/or separating activated regulatory th cells (treg)
10/04/2007WO2007110230A2 Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
10/04/2007WO2007109881A1 Biomarkers useful for diagnosing prostate cancer, and methods thereof
10/04/2007WO2007109833A1 Sampling and monitoring of particulate suspension material
10/04/2007WO2007109823A2 Peptide library
10/04/2007WO2007094754A3 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
10/04/2007WO2007093657A3 Method for the molecular diagnosis of prostate cancer and kit for implementing same
10/04/2007WO2007092579A9 Compositions and methods for capturing and analyzing cross-linked biomolecules
10/04/2007WO2007087013A3 Functional immunoassay
10/04/2007WO2007082734A3 Influenza vaccine
10/04/2007WO2007077257A3 Acne lesions biomarkers and modulators thereof
10/04/2007WO2007075642A3 Methods for assessing the pro-inflammatory immune health of an individual
10/04/2007WO2007075641A3 Methods for assessing the pro-inflammatory immune health of an individual
10/04/2007WO2007075523A3 Single-point measurement of high-z additives in sheets
10/04/2007WO2007070586A3 Dual transdermal analyte sensor assembly and methods of using the same
10/04/2007WO2007069089A3 Use of 4'-phosphopantetheinyl transferase as a target for identifying antibiotic molecules
10/04/2007WO2007066216A3 Fatty acids profile correlated to the propensity or risk of breast cancer
10/04/2007WO2007061520A3 Process and apparatus for combinatorial synthesis
10/04/2007WO2007054816A3 Antibody ultrahumanization by predicted mature cdr blasting and cohort library generation and screening
10/04/2007WO2007054791A3 Androgen glucuronides as markers of androgenic activity
10/04/2007WO2007053594A3 Large dynamic range proteomic analysis methods and compositions for practicing the same
10/04/2007WO2007049057A3 Novel fluorescent dyes and uses thereof
10/04/2007WO2007048830A3 Assays for histone deacetylase 1/2 selective inhibitors
10/04/2007WO2007046828A3 METHOD TO DECREASE NONSPECIFIC STAINING BY Cy5
10/04/2007WO2007045389A3 Method for discovering inhibitors of the epstein-barr virus-induced gene 3 (ebi3) and derivatives thereof for the treatment of metastasizing tumors and allergic asthma
10/04/2007WO2007044860A3 Diabetes-associated markers and methods of use thereof
10/04/2007WO2007044309A3 Device and method for inhibiting age complex formation
10/04/2007WO2007042946A3 Interleukin-8 labelled via one or more site specifically conjugated hydrazinonicotinamide (hynic) moieties and its use in diagnosis of infection and inflammation
10/04/2007WO2007042289A3 Nanobodies™ and polypeptides against egfr and igf-ir
10/04/2007WO2007041219A3 Compositions and methods for il13 biomarkers
10/04/2007WO2007040658A3 Ligand arrays having controlled feature size, and methods of making and using the same
10/04/2007WO2007035678A3 Methods of identifying agents having antiangiogenic activity
10/04/2007WO2007030012A3 Extracellular matrix imaging
10/04/2007WO2007028085A3 Neuregulin for prevention and treatment of damage from acute assault on vascular and neuronal tissues
10/04/2007WO2007027210A3 Multi-functional and configurable assays
10/04/2007WO2007026246A3 Synapse-specific proteins in glomeruli
10/04/2007WO2007024429A3 Cellular or organelle-entrapped nanoparticles
10/04/2007WO2007021860A3 QUANTITATIVE ASSAYS FOR PDGFR-β IN BODY FLUIDS
10/04/2007WO2007015170A3 Synapse-specific proteins in glomeruli
10/04/2007WO2007008471A3 Photolabile system with instantaneous fluorescence reporting function
10/04/2007WO2007005865A3 Novel bioassay system using a nanoparticle
10/04/2007WO2006127098A3 Method and test kit for the determination of iron content of in-use lubricants
10/04/2007WO2006119325A3 Using biological models
10/04/2007WO2006113610A3 Rapid exchange luminescence (rel) for high sensitivity detection
10/04/2007WO2006089009A8 Methods and compositions for the treatment of lipid-associated disorders
10/04/2007WO2006063800A8 Cloning of honey bee allergen
10/04/2007WO2006052788A3 Detection of activation of endothelial cells as surrogate marker for angiogenesis